Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma - Shen, Chenguang; Wang, Zhaoqin; Zhao, Fang; Yang, Yang; Li, Jinxiu; Yuan, Jing; Wang, Fuxiang; Li, Delin; Yang, Minghui; Xing, Li; Wei, Jinli; Xiao, Haixia; et al. (JAMA : the journal of the American Medical Association, 2020)
Keywords: Adult; Aged; Antibodies; Antibodies, Neutralizing - therapeutic use; Antibodies, Viral - blood; Antibodies, Viral - therapeutic use; Antiviral agents; Antiviral Agents - therapeutic use; Antiviral drugs; Betacoronavirus - immunology; Blood Donors; Body temperature; Chemical compounds; Clinical trials; Coronavirus Infections - drug therapy; Coronavirus Infections - physiopathology; Coronavirus Infections - therapy; Coronaviruses; COVID-19; Critical Illness; Dilution; Enzyme-linked immunosorbent assay; Female; Glucocorticoids - therapeutic use; Health services; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulin G - blood; Immunoglobulin M - blood; Infectious diseases; Male; Mechanical ventilation; Methylprednisolone; Methylprednisolone - therapeutic use; Middle Aged; Neutralization; Neutralizing; Online First; Organ Dysfunction Scores; Oxygenation; Pandemics; Patients; Pharmacology; Plasma; Pneumonia, Viral - drug therapy; Pneumonia, Viral - physiopathology; Pneumonia, Viral - therapy; Preliminary Communication; Respiratory diseases; Respiratory distress syndrome; Respiratory Distress Syndrome - therapy; SARS-CoV-2; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Transfusion; Ventilation; Ventilators; Viral diseases